In A549 lung cancer cells, MEK/ERK1-2 activation is required for quercetin induced apoptosis and inhibition of DNA synthesis thus providing a mechanism for the anti-cancer properties of this flavonoid (Nguyen et al., 2004). This evidence concerns the gene MAP2K7 and lung carcinoma.